Inventor · disambiguated record
Gene Liau
Also filed as: LIAU GENE
13 granted patents·9 pending applications·1,305 citations·filing 1995–2025
94Inventor score
Files withAMERICAN NAT RED CROSS10STOKE THERAPEUTICS INC7NOVARTIS AG2HUMAN GENOME SCIENCES INC1LIAU GENE1
Top patents by PatentIndex Score
22 records- 0197US6117425ASupplemented and unsupplemented tissue sealants, method of their production and useAMERICAN NAT RED CROSS·Filed 1995·Granted Sep 12, 2000·283 cites·57 claims
- 0296USRE39321ESupplemented and unsupplemented tissue sealants, methods of their production and useAMERICAN NAT RED CROSS·Filed 2003·Granted Oct 3, 2006·99 cites·48 claims
- 0395US6197325B1Supplemented and unsupplemented tissue sealants, methods of their production and useAMERICAN NAT RED CROSS·Filed 1995·Granted Mar 6, 2001·608 cites·48 claims
- 0493US7196054B1Methods for treating wound tissue and forming a supplemented fibrin matrixAMERICAN NAT RED CROSS·Filed 1995·Granted Mar 27, 2007·94 cites·39 claims
- 0592US7189410B1Supplemented and unsupplemented tissue sealants, methods of their production and useAMERICAN NAT RED CROSS·Filed 1995·Granted Mar 13, 2007·97 cites·78 claims
- 0691USRE39192ESupplemented and unsupplemented tissue sealants, methods of their production and useAMERICAN NAT RED CROSS·Filed 2003·Granted Jul 18, 2006·33 cites·57 claims
- 0789US11814622B2OPA1 antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2023·Granted Nov 14, 2023·1 cites·21 claims
- 0877USRE39298ESupplemented and unsupplemented tissue sealants, methods of their production and useAMERICAN NAT RED CROSS·Filed 2003·Granted Sep 19, 2006·24 cites·48 claims
- 0976US2024102011A1Opa1 antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1071US6610534B2Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinasesNOVARTIS AG·Filed 2001·Granted Aug 26, 2003·6 cites·12 claims
- 1169US12338437B2OPA1 antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2021·Granted Jun 24, 2025·0 cites·20 claims
- 1269US2024033378A1Antisense oligomers for treatment of non-sense mediated rna decay based conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1366US7229959B1Supplemented fibrin matrix delivery systemsAMERICAN NAT RED CROSS·Filed 1995·Granted Jun 12, 2007·49 cites·21 claims
- 1466US7153670B2Hyaluronan-binding proteins and encoding genesAMERICAN NAT RED CROSS·Filed 2004·Granted Dec 26, 2006·5 cites·16 claims
- 1554US2023116704A1Antisense oligomers for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1652US2021268667A1Antisense oligomers for treatment of non-sense mediated rna decay based conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1752US2007213255A1Novel Hyaluronan-Binding Proteins and Encoding GenesAMERICAN NAT RED CROSS·Filed 2006·Application pending·0 cites
- 1847US2004086487A1Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinasesNOVARTIS AG·Filed 2003·Application pending·0 cites
- 1944US2025243493A1Compounds for treatment of conditions and diseasesSTOKE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2043US2005202017A1Hb-954 as a target for modulating angiogenesisFiled 2003·Application pending·0 cites
- 2141US2006223756A1Endothelial cell specifically binding peptidesLIAU GENE·Filed 2003·Application pending·0 cites
- 2240US6872546B1Hyaluronan-binding proteins and encoding genesHUMAN GENOME SCIENCES INC·Filed 1999·Granted Mar 29, 2005·6 cites·56 claims
Join the waitlist — get patent alerts
Get an alert when Gene Liau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →